Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Aplaviroc studies in treatment-naive HIV patients halted over liver toxicity

Sep. 19, 2005

Phase II trial of TNX-355 for HIV recommended to continue

Sep. 16, 2005

In vitro and in vivo data on novel HIV integrase inhibitor

Sep. 14, 2005

Progenics updates findings on HIV entry inhibitor PRO-140

Sep. 13, 2005

Novel anti-HIV agents reported by Shionogi and AstraZeneca

Sep. 6, 2005

CADA - a potential anti-HIV CD4-targeting microbicide

Sep. 6, 2005

Novel HIV protease inhibitors with nanomolar potency and once-daily dosing possibility

Sep. 2, 2005

MIV-210 begins phase IIa study for HIV

Sep. 2, 2005

Pharmasset earns milestone for Reverset study results

Sep. 2, 2005

Maraviroc reported safe and effective in HIV infection

Aug. 31, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...